| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 130.715 | 499.321 | 421.636 | 428.450 |
| Total Income - EUR | - | - | - | - | - | - | 131.170 | 503.884 | 434.449 | 428.451 |
| Total Expenses - EUR | - | - | - | - | - | - | 112.263 | 422.509 | 415.598 | 424.229 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 18.907 | 81.375 | 18.851 | 4.222 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 17.618 | 76.490 | 14.444 | 3.267 |
| Employees | - | - | - | - | - | - | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Fitofarm Agrodan S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 60 | 60 | 60 | 60 |
| Current Assets | - | - | - | - | - | - | 125.075 | 265.467 | 399.134 | 411.960 |
| Inventories | - | - | - | - | - | - | 96.682 | 139.198 | 266.177 | 223.826 |
| Receivables | - | - | - | - | - | - | 27.801 | 123.508 | 128.913 | 182.283 |
| Cash | - | - | - | - | - | - | 592 | 2.761 | 4.044 | 5.850 |
| Shareholders Funds | - | - | - | - | - | - | 17.659 | 94.204 | 108.362 | 111.023 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 107.476 | 171.324 | 290.832 | 300.997 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4778 - 4778" | |||||||||
| CAEN Financial Year |
4778
|
|||||||||
Comments - Fitofarm Agrodan S.r.l.